Regulatory Updates
FDA, EMA, Health Canada rule changes that affect your submissions.
Free, no spam, unsubscribe anytime
Regulatory intelligence, delivered weekly
Stay ahead of FDA, EMA, and Health Canada changes. Get actionable insights on submissions, eCTD validation, and compliance without digging through Federal Register notices yourself.
What you'll get every week
Curated by regulatory professionals, not a content farm.
eCTD Best Practices
Validation tips, sequence structuring, and common rejection patterns.
Global Intelligence
Cross-jurisdiction insights for multi-market submissions.
Industry Trends
AI in regulatory, emerging guidelines, and operational benchmarks.
Compliance Alerts
Deadline reminders, PDUFA dates, and enforcement actions.
Product Updates
New Assyro features, workflows, and platform improvements.
Recent highlights
A sample of what recent issues covered.
- How ICH Q12 impacts your post-approval change strategy
- 5 eCTD validation errors that cause 80% of rejections
- FDA vs EMA: diverging expectations for Module 2.3
- Building a submission readiness checklist your team will use
Stop chasing regulatory updates
Let us bring the signal to you. One email per week, no fluff.